Theralase Technologies Inc (TLTFF)

[heavymetal]

the problem with this stock is there is there is a learning curve to understanding the biophysics, physical chemistry, and pharmacology of the drug and its method of operation.
sometimes the scientific papers have to be read with a medical dictionary beside you. the internet is a good dictionary.
the average investor is only interested in the end result and will not buy until success turns into the promise of income.
however big pharma knows when to jump in.
in my opinion we must be popping up on their sonar screens.
$^)